Global Healthcare Licensing - Medical Group Trends: Allergy & Immunology Mid-Year Review

  • ID: 4604847
  • Report
  • Region: Global
  • 74 pages
  • FinGlobe, Inc
1 of 3
This mid-year review report brings at one place all licensing deals and negotiations that took place between the healthcare companies of Japan, US and Europe during January 1, 2018 to June 30, 2018 for Allergy & Immunology medical group. Further, the licensing deals and negotiations that took place between the healthcare companies of other select regions and Japan, US and Europe for Allergy & Immunology medical group during this period are also studied and included here. Also, the licensing deals and negotiations that take place within the healthcare companies of Japan, US and Europe as well as within the healthcare companies of countries/regions other than Japan, US and Europe for Allergy & Immunology medical group are studied and included here. Moreover, all this collected data is comprehensively analyzed to understand the licensing trends and directions in the healthcare sector for Allergy & Immunology medical group during this time period.

Key Features:
  • 6 months’ Japan-US-Europe healthcare licensing transactions for Allergy & Immunology medical group at one place
  • 6 months’ other select regions healthcare licensing transactions for Allergy & Immunology medical group at one place
  • Small, medium and big multinational/non-multinational healthcare companies covered
  • Curated categorizations of licensing details
  • 8+ variables reflecting different forms of transactions done
  • Canada/Australia/NZ licensing trends with Japan-US-Europe for Allergy & Immunology medical group covered
  • Emerging markets licensing trends with Japan-US-Europe for Allergy & Immunology medical group covered
  • Licensing trends within Japan, US, Europe; and also within other select regions for Allergy & Immunology medical group covered
  • Licensing trends and directions for Allergy & Immunology medical group summarized
The Report is useful to:
  • Japan, US and Europe healthcare companies planning to introduce products related to Allergy & Immunology medical group in each other’s markets
  • Largecap companies of select other regions planning to introduce products related to Allergy & Immunology medical group in Japan, US and European markets
  • Select other regions’ largecap companies planning to introduce products related to Allergy & Immunology medical group in each other’s markets
  • Healthcare companies active in R&D related to Allergy & Immunology medical group and seeking new market base
  • Healthcare company executives negotiating licensing deals related to Allergy & Immunology medical group
  • Investors analyzing varied kinds of transaction options for licensing deals related to Allergy & Immunology medical group
Key analysis provided: January-June 2018
  • Total number of licensing deals signed for Allergy & Immunology medical group
  • Total number of companies/institutes involved in such licensing deals
  • Most licensing deals signed for Allergy & Immunology medical group by which country’s companies
  • Most licensing deals signed for Allergy & Immunology medical group by which sub-industry’s companies
  • Most licensing deals signed for Allergy & Immunology medical group by which market capitalization group’s companies
  • Number of inbound and outbound licensing deals for Allergy & Immunology medical group
  • Most licensing deals signed for Allergy & Immunology medical group by which medicine groups
  • Licensing payment arrangements most followed in the global licensing deals for Allergy & Immunology medical group
  • Number of domestic and worldwide licensing for Allergy & Immunology medical group
  • Number of R&D and commercialization licensing for Allergy & Immunology medical group
  • Number of licensing deals discontinued for Allergy & Immunology medical group
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Introduction

Research Design

Section 1: Inventions licensed for Allergy & Immunology medical group between healthcare companies of Japan and United States
1.1 By Japanese company name
1.2 By US company name
1.3 By Sub-industry
1.4 By Market capitalization groups
1.5 By Terms of payment

Section 2: Inventions licensed for Allergy & Immunology medical group between healthcare companies of Japan and Europe
2.1 By Japanese company name
2.2 By Europe company name
2.3 By Sub-industry
2.4 By Market capitalization groups
2.5 By Terms of payment

Section 3: Inventions licensed for Allergy & Immunology medical group between healthcare companies of United States and Europe
3.1 By US company name
3.2 By Europe company name
3.3 By Sub-industry
3.4 By Market capitalization groups
3.5 By Terms of payment

Section 4: Inventions licensed for Allergy & Immunology medical group between healthcare companies of Japan-US-Europe and other select regions
4.1 Canada/Asia/Australia/NZ licensing news with Japan-US-Europe
4.2 Emerging markets licensing news with Japan-US-Europe
4.3 Undisclosed companies’ licensing news with Japan-US-Europe

Section 5: Inventions licensed for Allergy & Immunology medical group within healthcare companies of Japan, United States and Europe
5.1 Japan-Japan licensing news
5.2 US-US licensing news
5.3 Europe-Europe licensing news

Section 6: Inventions licensed for Allergy & Immunology medical group among healthcare companies of countries/regions other than Japan-US-Europe

Section 7: Trends in Japan-US-Europe and other select regions’ licensing deals of healthcare companies for Allergy & Immunology medical group
7.1 Countries with most licensing deals
7.2 Healthcare sub-sector with most licensing deals
7.3 Market capitalization group with most licensing deals
7.4 Healthcare companies most active in outbound and inbound licensing deals
7.5 Licensing payment arrangements most followed
7.6 Worldwide licensing vs domestic licensing
7.7 R&D licensing vs commercialization licensing
7.8 Licensing deals which discontinued

Section 8: Trends and strategic directions

Appendices
Appendix 1 List of Japan-based healthcare companies covered in this report
Appendix 2 List of US-based healthcare companies covered in this report
Appendix 3 List of Europe-based healthcare companies covered in this report
Appendix 4 List of other select regions’ healthcare companies covered in this report
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll